Pulmonary Hypertension News Forums › Forums › PH Care and Treatment › Treatments and Therapies › PAH therapy Uptravi recommended for use through Scotland’s NHS

  • Treatments and Therapies

    PAH therapy Uptravi recommended for use through Scotland’s NHS

    Posted by Pulmonary Hypertension News Moderator on May 24, 2018 at 5:13 pm

    Scottish patients with pulmonary arterial hypertension (PAH) can now be treated with Actelion‘s Uptravi (selexipag) through the country’s National Health System (NHS) after a positive recommendation from the Scottish Medicines Consortium (SMC). However, the use of this therapy will be restricted to adult patients in WHO functional class 3 whose symptoms are not manageable or do not tolerate other available PAH therapies.

    Read more about this story here: Scottish Agency Recommends Uptravi for PAH Treatment Through National Health System

     

    Have you heard of selexipag? What do you think of this news?

    replied 6 years, 7 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .